Abiopharma

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

Altimmune to Participate in Two Upcoming Investor Conferences

Crescent Biopharma to Present at November Investor Conferences

Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates

Sonida Senior Living Announces Strategic Merger with CNL Healthcare Properties, Inc. in a Stock and Cash Transaction Valued at Approximately $1.8 Billion, Creating $3 Billion Pure-Play Senior Housing Owner-Operator

MediWound to Report Third Quarter 2025 Financial Results

Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors

Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Appili Therapeutics Announces Proposed Non-Brokered Private Placement

Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases